Comparative Pharmacology
Head-to-head clinical analysis: ALCAINE versus DURANEST.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ALCAINE versus DURANEST.
ALCAINE vs DURANEST
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Local anesthetic that stabilizes the neuronal membrane by inhibiting sodium ion influx, thereby blocking nerve impulse transmission.
Etonidate is an ultrashort-acting nonbarbiturate hypnotic agent that produces anesthesia by enhancing GABA-mediated chloride conductance at GABA-A receptors, leading to central nervous system depression.
1 to 2 drops of 0.5% solution topically to the eye, repeated as needed for anesthesia.
2-10 mL of a 1-2% solution, subarachnoid injection, single dose only.
None Documented
None Documented
Terminal elimination half-life: 0.4–1.2 minutes (rapid enzymatic hydrolysis by plasma esterases); clinical significance: ultra-short duration limits systemic toxicity.
Terminal elimination half-life is 4.5 hours (range 3-6 hours). Clinical context: Prolonged in severe hepatic impairment but not significantly in renal impairment.
Renal excretion of parent drug and metabolites: <5% unchanged.
Primarily hepatic metabolism; renal excretion of metabolites accounts for <10% unchanged drug. Biliary/fecal elimination is minimal.
Category C
Category C
Local Anesthetic
Local Anesthetic